TransMedics Group Inc (TMDX)

Return on assets (ROA)

		Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Net income (ttm)	US$ in thousands	32,638	3,000	-10,195	-25,028	-35,779	-17,783	-28,305	-36,231	-42,179	-47,715	-46,860	-44,215	-37,858	-29,984	-27,813	-28,748	-31,614	-34,806	-35,504	-33,547
Total assets	US$ in thousands	785,571	758,577	723,831	706,047	689,227	690,358	287,088	277,147	274,873	117,285	124,008	134,893	131,146	140,512	145,783	152,026	159,322	163,137	96,923	105,299
ROA		4.15%	0.40%	-1.41%	-3.54%	-5.19%	-2.58%	-9.86%	-13.07%	-15.34%	-40.68%	-37.79%	-32.78%	-28.87%	-21.34%	-19.08%	-18.91%	-19.84%	-21.34%	-36.63%	-31.86%

September 30, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $32,638K ÷ $785,571K
= 4.15%

TransMedics Group Inc's return on assets (ROA) has fluctuated over the past several quarters, ranging from -40.68% to 4.15%. The ROA turned negative and reached its lowest point of -40.68% in the third quarter of 2022 before gradually improving in subsequent quarters.

The negative ROA figures indicate that the company's assets have not been effectively utilized to generate profits during those periods. However, the positive ROA of 4.15% in the most recent quarter suggests that TransMedics Group Inc has been more efficient in generating profit relative to its assets.

Overall, the trend in ROA indicates that TransMedics Group Inc may have had challenges in optimizing its asset efficiency in the past but has shown some improvement in the most recent quarter. Further analysis and monitoring of the company's asset management practices are recommended to ensure sustained profitability.